Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Hsp90 is a molecular chaperone for many signal transducers and may influence evolution by releasing previously silent genetic variation in response to environmental change. In fungi separated by ∼800 million years of evolution, Hsp90 potentiated the evolution of drug resistance in a different way, by enabling new mutations to have immediate phenotypic consequences. Resistance was abrogated by Hsp90 inhibitors and by febrile temperatures, suggesting new therapeutic strategies and a clinical benefit of fever. During selection in a human host, drug resistance that was initially Hsp90-dependent evolved toward independence. Thus, Hsp90 can act in diverse ways to couple environmental contingency to the emergence and fixation of new traits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibitors of heat shock protein 90 (Hsp90)82, calcineurin21,25,26, target of rapamycin (TOR)83 and mutants that affect Rim10184 (a transcription factor involved in the pH response pathway) effectively eliminate tolerance and greatly increase the fungicidal activity [G] of fluconazole across a diverse set of isolates with different tolerance levels (Fig. 1E; Box 5).”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [82]
In the citing paper
“The importance of rendering FLC fungicidal in treating IFIs arises from the increasing prevalence of acquired FLC resistance and the persistent nature of fungal infections attributed to the fungistatic properties of FLC [10,11,12].”
From Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species (2024) · cites this paper as [10]
In the citing paper
“When large numbers of cells are plated on a high concentration of fluconazole, a rapid adaptation to decreased susceptibility has been observed in wild-type cells (25).”
From Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants (2013) · cites this paper as [25]
In the citing paper
“A strain with genetically reduced Hsp90 levels (Lo90 [21]) had a modest reduction in tolerance, however, a concentration the Hsp90 inhibitor GdA that abrogates azole resistance had no effect on MF tolerance (Figure 9D).”
From Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin (2009) · cites this paper as [21]
In the citing paper
“A strain with genetically reduced Hsp90 levels (Lo90 [21]) had a modest reduction in tolerance, however, a concentration the Hsp90 inhibitor GdA that abrogates azole resistance had no effect on MF tolerance (Figure 9D).”
From Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin (2009) · cites this paper as [21]
42 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hsp90 as a capacitor for morphological evolution
Rutherford, S. L., & Lindquist, S. (1998) · Nature · doi:10.1038/24550 · Cited by 2,270
Self-citationPratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Hsp90 as a capacitor of phenotypic variation
Queitsch, C., Sangster, T. A., & Lindquist, S. (2002) · Nature · doi:10.1038/nature749 · Cited by 1,372
Self-citationClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202
Kirschner, M., & Gerhart, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8420 · Cited by 1,129
Molecular Evidence for the Early Colonization of Land by Fungi and Plants
Heckman, D. S., Geiser, D. M., Eidell, B. R., Stauffer, R. L., Kardos, N. L., & Hedges, S. B. (2001) · Science · doi:10.1126/science.1061457 · Cited by 1,020
Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980403y · Cited by 1,004
Young, J. C., Moarefi, I., & Hartl, F. U. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104079 · Cited by 822
Research works printed but not linked: 1
- J. R. Blankenship, W. J. Steinbach, J. R. Perfect, J. Heitman, Curr. Opin. Investig. Drugs4, 192 (2003).
Cited by
Items 101–200 of 705
García‐Effrón, G. (2020) · Journal of Fungi · doi:10.3390/jof6040262 · Cited by 143
HSP90-buffered genetic variation is common in Arabidopsis thaliana
Sangster, T. A., Salathia, N., Lee, H. N., Watanabe, E., Schellenberg, K., Morneau, K., Wang, H., Undurraga, S., Queitsch, C., & Lindquist, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712210105 · Cited by 131
Self-citationCavefish and the basis for eye loss
Krishnan, J., & Rohner, N. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0487 · Cited by 138
Fan, F., Liu, Y., Liu, Y., Lv, R., Sun, W., Ding, W., Cai, Y., Li, W., Liu, X., & Qu, W. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106673 · Cited by 159
Hsp90 orchestrates stress response signaling governing fungal drug resistance
Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000471 · Cited by 130
“fumigatus[7] and against the emerging pathogen Aspergillus terreus[6].”
Self-citationThe structural and functional diversity of Hsp70 proteins from Plasmodium falciparum
Shonhai, A., Boshoff, A., & Blatch, G. L. (2007) · Protein Science · doi:10.1110/ps.072918107 · Cited by 130
“In addition, there is evidence that links heat shock proteins with drug resistance, and both heat shock protein 90 (Hsp90) and its functional partner calcineurin have been implicated (Sanglard et al. 2003; Cowen and Lindquist 2005).”
BackgroundEmerging New Targets for the Treatment of Resistant Fungal Infections
Liu, N., Tu, J., Dong, G., Wang, Y., & Sheng, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01413 · Cited by 139
Cryptic genetic variation accelerates evolution by opening access to diverse adaptive peaks
Zheng, J., Payne, J. L., & Wagner, A. (2019) · Science · doi:10.1126/science.aax1837 · Cited by 139
Systems Analysis of Chaperone Networks in the Malarial Parasite Plasmodium falciparum
Pavithra, S. R., Kumar, R., & Tatu, U. S. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030168 · Cited by 132
“albicans in a calcineurin (also known as protein phosphatase PP5)–dependent manner [33].”
BackgroundResultBranco, J., Miranda, I. M., & Rodrigues, A. G. (2023) · Journal of Fungi · doi:10.3390/jof9010080 · Cited by 164
The Future of Antifungal Drug Therapy: Novel Compounds and Targets
Mota Fernandes, C., Dasilva, D., Haranahalli, K., McCarthy, J. B., Mallamo, J., Ojima, I., & Del Poeta, M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01719-20 · Cited by 124
Lysine Deacetylases Hda1 and Rpd3 Regulate Hsp90 Function thereby Governing Fungal Drug Resistance
Robbins, N., Leach, M. D., & Cowen, L. E. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.035 · Cited by 126
“…Given that KDACs regulate Hsp90 function in mammalian cells (Aoyagi and Archer, 2005) and that Hsp90 potentiates the emergence and maintenance of fungal drug resistance (Cowen and Lindquist, 2005), we hypothesized that KDACs govern fungal drug resistance by regulating Hsp90 function in fungi.”
BackgroundResultInfluentialSelf-citationThe genome‐centric concept: resynthesis of evolutionary theory
Heng, H. H. (2009) · BioEssays · doi:10.1002/bies.200800182 · Cited by 138
“Examples include the adaptive chromosomal inversions observed in Drosophila,((79)) human populations((80)) and other systems.((15,45,69)) The variations within species come from interaction between all levels of genetic organization and environment.”
BackgroundStructural basis for species-selective targeting of Hsp90 in a pathogenic fungus
Whitesell, L., Robbins, N., Huang, D. S., McLellan, C. A., Shekhar-Guturja, T., LeBlanc, E. V., Nation, C. S., Hui, R., Hutchinson, A., Collins, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08248-w · Cited by 124
Self-citationTrithorax requires Hsp90 for maintenance of active chromatin at sites of gene expression
Tariq, M., Nussbaumer, U., Chen, Y., Beisel, C., & Paro, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809669106 · Cited by 133
“Surprisingly, Hsp90-dependent phenotypic alterations were shown to become fixed and inherited in subsequent generations, independent of the original Hsp90 perturbations, thereby providing a stage for the evolution of new traits (11, 12).”
BackgroundGomes, A. C., Miranda, I., Silva, R. M., Moura, G. R., Thomas, B., Akoulitchev, A., & Santos, M. A. (2007) · Genome Biology · doi:10.1186/gb-2007-8-10-r206 · Cited by 120
“albicans, Hsp90 plays a critical role in drug resistance by maintaining mutant drug resistance genes in a functional state [51].”
BackgroundDefining the frontiers between antifungal resistance, tolerance and the concept of persistence
Delarze, E., & Sanglard, D. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.001 · Cited by 118
“In yeast, Hsp90 can therefore determine the fate and trajectory of antifungal resistance, a concept that was addressed and verified in S. cerevisiae (Cowen and Lindquist, 2005).”
BackgroundInfluentialJuvvadi, P. R., Lamoth, F., & Steinbach, W. J. (2014) · Fungal Biology Reviews · doi:10.1016/j.fbr.2014.02.004 · Cited by 116
“Hsp90 was shown to have a key role in the acquisition and evolution of resistance to azoles and echinocandins, and growing evidence suggests that this inherent resistance mechanism is mediated via calcineurin (Cowen et al., 2006; Cowen and Lindquist, 2005; Cowen et al., 2009; Singh et al., 2009).”
BackgroundInfluentialDhingra, S., & Cramer, R. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00092 · Cited by 115
“Hsp90 is molecular chaperone that regulates diverse client proteins, many of which are involved in cell signaling (Cowen and Lindquist, 2005).”
BackgroundShonhai, A., Maier, A. G., Przyborski, J. M., & Blatch, G. L. (2011) · Protein and Peptide Letters · doi:10.2174/092986611794475002 · Cited by 124
“In addition, Hsp90 has been implicated in the development 639 of drug resistance in fungi by acting as an “evolutionary” capacitor [109].”
BackgroundMolecular basis of antifungal drug resistance in yeasts
Morio, F., Jensen, R. H., Le Pape, P., & Arendrup, M. C. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.012 · Cited by 114
Lu, X., Xiao, L., Wang, L., & Ruden, D. M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.11.011 · Cited by 130
“In 2005, Cowen and Lindquist showed that high levels of Hsp90 facilitated the evolution of drug resistance in diverse species of fungi by altering the activities of mutated drug resistance genes [70].”
BackgroundSionov, E., Chang, Y. C., & Kwon-Chung, K. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00694-13 · Cited by 112
“In Saccharomyces cerevisiae and Candida albicans, Hsp90 is reported to potentiate adaptation of cells to various unrelated cytotoxic compounds, including fluconazole, by means of induction of aneuploidy (10, 11).”
BackgroundDiezmann, S., Michaut, M., Shapiro, R. S., Bader, G. D., & Cowen, L. E. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002562 · Cited by 112
“We previously established that Hsp90 regulates the emergence and maintenance of resistance to the most widely deployed classes of antifungal drugs in the clinic, the azoles and echinocandins [6,15,18,19].”
BackgroundSelf-citationGassen, N. C., Fries, G. R., Zannas, A. S., Hartmann, J., Zschocke, J., Hafner, K., Carrillo-Roa, T., Steinbacher, J., Preißinger, S. N., Hoeijmakers, L., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aac7695 · Cited by 107
Fungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs
Leach, M. D., Klipp, E., Cowen, L. E., & Brown, A. J. P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2875 · Cited by 107
Self-citationThe Yeast Environmental Stress Response Regulates Mutagenesis Induced by Proteotoxic Stress
Shor, E., Fox, C. A., & Broach, J. R. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003680 · Cited by 106
“resistance in fungal pathogens [6,55].”
It’s not magic – Hsp90 and its effects on genetic and epigenetic variation
Zabinsky, R. A., Mason, G. A., Queitsch, C., & Jarosz, D. F. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.05.015 · Cited by 118
Nishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
Gong, Y., Li, T., Yu, C., & Sun, S. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00520 · Cited by 114
“Calcineurin is a heterodimer composed of a catalytic subunit (either Cna1 or Cna2) and an activating regulatory subunit (Cnb1) (Cowen and Lindquist, 2005).”
BackgroundAneuploidy Enables Cross-Adaptation to Unrelated Drugs
Yang, F., Teoh, F., Tan, A. S. M., Cao, Y., Pavelka, N., & Berman, J. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz104 · Cited by 101
“Eukaryotic cells adapt to a broad range of stresses, with a classic example being the rapid adaptation of yeast cells to antifungal therapies (Cowen and Lindquist 2005; Bennett et al. 2014; Berman 2016).”
BackgroundDual action antifungal small molecule modulates multidrug efflux and TOR signaling
Shekhar-Guturja, T., Gunaherath, G. M. K. B., Wijeratne, E. M. K., Lambert, J.-P., Averette, A. F., Lee, S. C., Kim, T., Bahn, Y.-S., Tripodi, F., Ammar, R., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2165 · Cited by 101
Self-citationLamping, E., Ranchod, A., Nakamura, K., Tyndall, J. D. A., Niimi, K., Holmes, A. R., Niimi, M., & Cannon, R. D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01095-08 · Cited by 100
“Hsp90-dependent calcineurin stress response pathway (3, 5, 6).”
BackgroundElucidating Drug Resistance in Human Fungal Pathogens
Xie, J. L., Polvi, E. J., Shekhar‐Guturja, T., & Cowen, L. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.18 · Cited by 127
Self-citationThe inoculum effect and band‐pass bacterial response to periodic antibiotic treatment
Tan, C., Smith, R. P., Srimani, J. K., Riccione, K. A., Prasada, S., Kuehn, M. J., & You, L. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.49 · Cited by 113
“As higher protein stability could increase microbial survival rates in the presence of drug (Cowen and Lindquist, 2005), this response is unlikely to contribute to generation of IE as its effect would be independent of cell density (Figure 2A).”
Molecular Aspects of the Stress Response: Chaperones, Membranes and Networks
Csermely, P., & VÃgh, L. (2007) · Springer eBooks · doi:10.1007/978-0-387-39975-1 · Cited by 104
pH Signaling in Human Fungal Pathogens: a New Target for Antifungal Strategies
Cornet, M., & Gaillardin, C. (2014) · Eukaryotic Cell · doi:10.1128/ec.00313-13 · Cited by 98
“fumigatus and Aspergillus terreus (129, 135).”
Techniques for the Assessment of In Vitro and In Vivo Antifungal Combinations
Bidaud, A.-L., Schwarz, P., Herbreteau, G., & Dannaoui, É. (2021) · Journal of Fungi · doi:10.3390/jof7020113 · Cited by 114
Selection Transforms the Landscape of Genetic Variation Interacting with Hsp90
Geiler‐Samerotte, K., Zhu, Y. O., Goulet‐Scott, B. E., Hall, D. W., & Siegal, M. L. (2016) · PLoS Biology · doi:10.1371/journal.pbio.2000465 · Cited by 100
Sun, N., Fonzi, W., Chen, H., She, X., Zhang, L., Zhang, L., & Calderone, R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01520-12 · Cited by 94
“When large numbers of cells are plated on a high concentration of fluconazole, a rapid adaptation to decreased susceptibility has been observed in wild-type cells (25).”
BackgroundLi, P., Seneviratne, C. J., Alpi, E., Vizcaino, J. A., & Jin, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-15 · Cited by 95
“HSP90 is a key regulator of cell circuitry and plays an important role in potentiating fungal resistance (50, 51).”
BackgroundGenetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations
Hill, J. A., Ammar, R., Torti, D., Nislow, C., & Cowen, L. E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003390 · Cited by 93
“While this patient was not treated with Hsp90 or calcineurin inhibitors, fever may have provided the selection for Hsp90 independence given that febrile temperatures cause global problems in protein folding that can overwhelm Hsp90 function and reduce azole resistance in a manner that phenocopies Hsp90 inhibition [16].”
BackgroundResultInfluentialSelf-citationThe fungal Achilles’ heel: targeting Hsp90 to cripple fungal pathogens
Cowen, L. E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.005 · Cited by 104
Self-citationDevelopmental capacitance, genetic accommodation, and adaptive evolution
Moczek, A. P. (2007) · Evolution & Development · doi:10.1111/j.1525-142x.2007.00162.x · Cited by 103
“The more canalized a developmental process, the more robust it is to perturbations through variation in genetic and environmental inputs.”
BackgroundHsp90 and the quantitative variation of wing shape in Drosophila melanogaster.
Debat, V., Milton, C. C., Rutherford, S., Klingenberg, C. P., & Hoffmann, A. A. (2006) · PubMed · Cited by 95
Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi
Hokken, M., Zwaan, B. J., Melchers, W. J. G., & Verweij, P. E. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103254 · Cited by 110
The Hsp70-Chaperone Machines in Bacteria
Mayer, M. P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.694012 · Cited by 92
“For Hsp90 it was shown that development of resistance to antimicrobial drugs depends on this chaperone (Cowen and Lindquist, 2005).”
BackgroundHSP90: Enabler of Cancer Adaptation
Jaeger, A. M., & Whitesell, L. J. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055533 · Cited by 99
“These results are reminiscent of the dramatic effects of low-level HSP90 inhibition seen on the emergence of resistance to conventional antimycotics in pathogenic fungi (Cowen & Lindquist 2005, Cowen et al. 2009).”
ResultGenetic Mechanisms Controlling Cardiovascular Development
Bentham, J., & Bhattacharya, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1420.003 · Cited by 105
Comprehensive fitness maps of Hsp90 show widespread environmental dependence
Flynn, J. M., Rossouw, A., Cote-Hammarlof, P., Fragata, I., Mavor, D., Hollins, C., Bank, C., & Bolon, D. N. (2020) · eLife · doi:10.7554/elife.53810 · Cited by 91
Shahinas, D., Liang, M., Datti, A., & Pillai, D. R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901796s · Cited by 91
The Hsp90 chaperone network modulates Candida virulence traits
O’Meara, T. R., Robbins, N., & Cowen, L. E. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.05.003 · Cited by 92
Correia, A. L., Mori, H., Chen, E. I., Schmitt, F. C., & Bissell, M. J. (2013) · Genes & Development · doi:10.1101/gad.211383.112 · Cited by 94
“We are now beginning to understand that HSP90’s functions extend well beyond stress tolerance, and associated changes in its clients can then exert marked effects on the relationship between genotype and phenotype, influencing human health, disease, and evolutionary processes (Rutherford and Lindquist 1998; Queitsch e…”
BackgroundCalcineurin Regulation in Fungi and Beyond
Stie, J., & Fox, D. S. (2007) · Eukaryotic Cell · doi:10.1128/ec.00326-07 · Cited by 99
The role of Candida albicans stress response pathways in antifungal tolerance and resistance
Iyer, K. R., Robbins, N., & Cowen, L. E. (2022) · iScience · doi:10.1016/j.isci.2022.103953 · Cited by 88
“For example, loss-of-function mutations in ERG3 lead to azole resistance that is calcineurin dependent (Cowen and Lindquist, 2005).”
BackgroundInfluentialSelf-citationModelling the Role of the Hsp70/Hsp90 System in the Maintenance of Protein Homeostasis
Proctor, C. J., & Lorimer, I. A. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022038 · Cited by 93
“This is consistent with experimental data described in the Introduction, which show that the capacity of chaperone systems can be exceeded under conditions of high external stress [22,23].”
BackgroundResultDrug resistance mechanisms and their regulation in non-albicans Candida species
Kołaczkowska, A., & Kołaczkowski, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv445 · Cited by 87
Combinatorial stresses kill pathogenic Candida species
Kaloriti, D., Tillmann, A., Cook, E., Jacobsen, M., You, T., Lenardon, M., Ames, L., Barahona, M., Chandrasekaran, K., Coghill, G., et al. (2012) · Medical Mycology · doi:10.3109/13693786.2012.672770 · Cited by 86
HSP90 as a platform for the assembly of more effective cancer chemotherapy
Whitesell, L. J., & Lin, N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.12.006 · Cited by 95
STRESS PROTEIN EXPRESSION KINETICS
Diller, K. R. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.7.060804.100449 · Cited by 95
The Hsp90 Co-Chaperone Sgt1 Governs Candida albicans Morphogenesis and Drug Resistance
Shapiro, R. S., Zaas, A. K., Betancourt-Quiroz, M., Perfect, J. R., & Cowen, L. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044734 · Cited by 86
“Having determined that depletion of Sgt1 phenocopies depletion of Hsp90 in terms of morphogenesis, we next assessed whether Sgt1 played a role in antifungal tolerance and resistance, as Hsp90 enables crucial cellular responses to drug-induced stress [35,37].”
BackgroundMethodSelf-citationVisualizing high error levels during gene expression in living bacterial cells
Meyerovich, M., Mamou, G., & Ben‐Yehuda, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912989107 · Cited by 86
Histone Deacetylases and Their Inhibition in Candida Species
Garnaud, C., Champleboux, M., Maubon, D., Cornet, M., & Govin, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01238 · Cited by 96
“Hda1 and Rpd3 control the acetylation of Hsp90, a protein involved in the development of drug resistance in various fungi (Cowen and Lindquist, 2005; Robbins et al., 2012).”
BackgroundProtein Folding Sculpting Evolutionary Change
Lindquist, S. (2009) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2009.74.043 · Cited by 92
“the specific effects of Hsp90 inhibition [11].”
BackgroundInfluentialSelf-citationDrug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis
Murphy, S. E., & Bicanic, T. A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.759408 · Cited by 101
Antifungal activity of redox-active benzaldehydes that target cellular antioxidation
Jong Heon, K. I. M., Chan, K. L., Mahoney, N. E., & Campbell, B. C. (2011) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-10-23 · Cited by 83
“Alternatively, drug resistance was abrogated by applying inhibitors of Hsp90 [67].”
BackgroundInfluentialStukenbrock, E. H., & Croll, D. (2014) · Fungal Biology Reviews · doi:10.1016/j.fbr.2014.02.001 · Cited by 92
Fitness Trade-Offs Associated with the Evolution of Resistance to Antifungal Drug Combinations
Hill, J. A., O’Meara, T. R., & Cowen, L. E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.009 · Cited by 80
Self-citationShapiro, R. S., Sellam, A., Tebbji, F., Whiteway, M., Nantel, A., & Cowen, L. E. (2012) · Current Biology · doi:10.1016/j.cub.2012.01.062 · Cited by 81
Self-citationThe Effect of Chaperonin Buffering on Protein Evolution
Williams, T. A., & Fares, M. A. (2010) · Genome Biology and Evolution · doi:10.1093/gbe/evq045 · Cited by 80
“Since this initial discovery, Hsp90-buffered variation has been documented in other eukaryotes including Saccharo- myces cerevisiae (Cowen and Lindquist 2005) and Arabi- dopsis thaliana (Sangster et al. 2007, 2008).”
BackgroundBendaha, H., Yu, L. X., Touzani, R., Souane, R., Giaever, G. N., Nislow, C., Boone, C. M., Kadiri, S. E., Brown, G. W., & Bellaoui, M. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.06.012 · Cited by 86
Singh, B. N., Upreti, D. K., Singh, B. R., Pandey, G., Verma, S., Roy, S., Naqvi, A. H., & Rawat, A. K. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03599-14 · Cited by 84
Targeting chaperones in transformed systems – a focus on Hsp90 and cancer
Chiosis, G. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.37 · Cited by 80
“has shown that Hsp90 may also enable pathogenic fungi to rapidly develop drug resistance unveiling yet another face of the chaperone [124].”
BackgroundEpigenetic mechanisms of drug resistance in fungi
Chang, Z., Yadav, V., Lee, S. C., & Heitman, J. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103253 · Cited by 92
“While the exact mode of action for most of these deacetylases remains to be elucidated, studies in both Candida and Aspergillus suggested a role for Hsp90 in this process (Cowen and Lindquist, 2005; Lamoth et al., 2015).”
BackgroundThe contribution of Aspergillus fumigatus stress responses to virulence and antifungal resistance
Brown, N. A., & Goldman, G. H. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-5510-4 · Cited by 86
Nilsson, J., Grahn, M., & Wright, A. P. H. (2011) · Genome biology · doi:10.1186/gb-2011-12-7-r65 · Cited by 84
“This capacity may either entail a reduction in the potential lethality of mutations or a reduction in the number of mutations required to generate phenotypically novel traits [14-17].”
BackgroundResistance mechanism and proteins in Aspergillus species against antifungal agents
Shishodia, S. K., Tiwari, S., & Shankar, J. (2019) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2019.1574927 · Cited by 96
HSP90 Inhibitors for Cancer Therapy and Overcoming Drug Resistance
Jhaveri, K. L., & Modi, S. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-397927-8.00015-4 · Cited by 84
The Hsp90 chaperone machinery: from structure to drug development
Hahn, J. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.10.623 · Cited by 82
Jin, X., Zhang, M., Lu, J., Duan, X., Chen, J., Liu, Y., Chang, W., & Lou, H. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.06.016 · Cited by 75
“albicans has developed multiple stress response pathways to adapt to host conditions and promote the evolution of drug resistance [35].”
BackgroundUsing Combination Therapy to Thwart Drug Resistance
Hill, J. A., & Cowen, L. E. (2015) · Future Microbiology · doi:10.2217/fmb.15.68 · Cited by 75
Self-citationSikkink, K. L., Reynolds, R. M., Ituarte, C. M., Cresko, W. A., & Phillips, P. C. (2014) · G3 Genes Genomes Genetics · doi:10.1534/g3.114.010553 · Cited by 90
“…responses to stress (Lindquist and Craig 1988) and acting as a capacitor for environmentally sensitive variation (Rutherford and Lindquist 1998; Cowen and Lindquist 2005; Sangster et al. 2008; Jarosz and Lindquist 2010; Rohner et al. 2013), little is known about where genetic variation for…”
BackgroundHarmine Is a Potent Antimalarial Targeting Hsp90 and Synergizes with Chloroquine and Artemisinin
Shahinas, D., MacMullin, G., Benedict, C., Crandall, I., & Pillai, D. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00328-12 · Cited by 74
“Hsp90 is a highly conserved chaperone among eukaryotes containing an N terminus ATPase domain, a central acidic hinge region, and a COOH-terminal substrate-binding domain (6, 9, 19, 24).”
BackgroundLamoth, F., Juvvadi, P. R., Soderblom, E. J., Moseley, M. A., Asfaw, Y. G., & Steinbach, W. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02286-13 · Cited by 74
“Fungal Hsp90 promotes resistance to azole and echinocandin drugs, which has been well demonstrated in the pathogenic yeast Candida albicans (6, 10, 11).”
BackgroundDevelopmental plasticity and the evolution of animal complex life cycles
Minelli, A., & Fusco, G. (2010) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2009.0268 · Cited by 72
“…developmental sequences thus set in motion can occasionally turn out as ‘natural capacitors for cryptic genetic variation’ (Moczek 2007, p. 301; see also Rutherford & Lindquist 1998; Queitsch et al. 2002; Cowen & Lindquist 2005; Dworkin 2005a,b; Nijhout et al. 2006; Suzuki & Nijhout 2006).”
BackgroundAspergillus terreus: Novel lessons learned on amphotericin B resistance
Posch, W., Blatzer, M., Wilflingseder, D., & Lass‐Flörl, C. (2018) · Medical Mycology · doi:10.1093/mmy/myx119 · Cited by 82
Environmental robustness of the global yeast genetic interaction network
Costanzo, M., Hou, J., Messier, V., Nelson, J., Rahman, M., VanderSluis, B., Wang, W., Pons, C., Ross, C., Ušaj, M., et al. (2021) · Science · doi:10.1126/science.abf8424 · Cited by 79
A CRISPR Interference Platform for Efficient Genetic Repression in Candida albicans
Wensing, L. F., Sharma, J., Uthayakumar, D., Proteau, Y., Chavez, A., & Shapiro, R. S. (2019) · mSphere · doi:10.1128/msphere.00002-19 · Cited by 75
“We monitored resistance to the azole antifungals fluconazole and miconazole, as repression of HSP90 has been shown to abrogate resistance to these drugs (66, 68).”
BackgroundHuman Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis
Bugli, F., Cacaci, M., Martini, C., Torelli, R., Posteraro, B., Sanguinetti, M., & Sterbini, F. P. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/403121 · Cited by 79
“Prejudice Hsp90 or calcineurin function converts antifungal drugs from fungistatic to fungicidal and enhances the efficacy of antifungals in mammalianmodels of systemic and biofilm fungal infections [36].”
BackgroundThe Molecular Chaperone DnaK Is a Source of Mutational Robustness
Aguilar-Rodríguez, J., Sabater‐Muñoz, B., Montagud‐Martínez, R., Berlanga, V., Alvarez‐Ponce, D., Wagner, A., & Fares, M. A. (2016) · Genome Biology and Evolution · doi:10.1093/gbe/evw176 · Cited by 70
Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p
Tong, Y., Zhang, J., Sun, N., Wang, X.-M., Wei, Q., Zhang, Y., Huang, R., Pu, Y., Dai, H., Ren, B., et al. (2021) · Science Bulletin · doi:10.1016/j.scib.2020.12.035 · Cited by 70
Micorriza arbuscular e a tolerância das plantas ao estresse
Folli‐Pereira, M. D. S., Meira-Haddad, L. S., Bazzolli, D. M. S., & Kasuya, M. C. M. (2012) · Revista Brasileira de Ciência do Solo · doi:10.1590/s0100-06832012000600001 · Cited by 70
Stress-Induced Mutagenesis, Gambler Cells, and Stealth Targeting Antibiotic-Induced Evolution
Pribis, J. P., Zhai, Y., Hastings, P. J., & Rosenberg, S. M. (2022) · mBio · doi:10.1128/mbio.01074-22 · Cited by 77
“Candida albicans, HSP90 inhibitors (159) and the natural product beauvericin (160) pre-”
BackgroundAging cellular networks: Chaperones as major participants
Sőti, C., & Csermely, P. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.017 · Cited by 70
“whole organism, chaperones act as a buffer to conceal the phenotype of the genetic changes in a large variety of organisms (Rutherford and Lindquist, 1998; Fares et al., 2002; Queitsch et al., 2002; Cowen and Lindquist, 2005). In aging organisms protein damage becomes prevalent: e.g., in an eighty year old human half…”
BackgroundHSP 90 and co‐chaperones: a multitaskers’ view on plant hormone biology
Donato, M. D., & Geisler, M. M. (2019) · FEBS Letters · doi:10.1002/1873-3468.13499 · Cited by 78
Pfaller, M. A., Rhomberg, P. R., Messer, S. A., & Castanheira, M. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.11.008 · Cited by 67
Senn, H., Shapiro, R. S., & Cowen, L. E. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-08-0729 · Cited by 67
“albicans (Cowen and Lindquist, 2005; Shapiro et al., 2009; Singh et al., 2009).”
BackgroundSelf-citationSynergistic and antagonistic drug interactions in the treatment of systemic fungal infections
Wambaugh, M. A., Denham, S. T., Ayala, M., Brammer, B., Stonhill, M. A., & Brown, J. C. (2020) · eLife · doi:10.7554/elife.54160 · Cited by 65
“Synergistic combination therapies are increasingly important clinical options, especially for drug resistant microbes (Cowen and Lindquist, 2005; Kalan and Wright, 2011; Uppuluri et al., 2008; Zheng et al., 2018).”
BackgroundLinking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 77
“albicans, as described above, which both enhances antifungal activity, and induces filamentous growth [72,123,187,254].”
BackgroundUnderstanding the mechanisms of resistance to azole antifungals in Candida species
Li, Y., Hind, C. K., Furner-Pardoe, J., Sutton, J. M., & Rahman, K. M. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf106 · Cited by 77
Metadata
- Authors
- Cowen, L. E., & Lindquist, S.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Lindquist, Susan
- ORCID
- Cowen, Leah E.
- Venue
- Science
- Published
- 2005-09-30
- Volume
- 309
- Issue
- 5744
- Pages
- 2185-2189
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1988825409
- Cited by
- 698
- References
- 36
- Citations by year
- 2026: 21 · 2025: 32 · 2024: 46 · 2023: 30 · 2022: 30 · 2021: 38 · 2020: 34 · 2019: 42 · 2018: 36 · 2017: 25 · 2016: 34 · 2015: 36 · 2014: 39 · 2013: 40 · 2012: 47
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (P30ES002109, P30ES-02109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- HSP90, molecular chaperones, drug resistance, fungi, Hsp90 inhibitors, fever, febrile temperature, signal transducers, treatment options
- MeSH terms
- Caspofungin, Antifungal Agents, Aspergillosis, Aspergillus, Candida albicans, Candidiasis, Ergosterol, Biological Evolution, Humans, Mutation, Peptides, Cyclic, Phenotype, Saccharomyces cerevisiae, Selection, Genetic, Fluconazole, AIDS-Related Opportunistic Infections, HSP90 Heat-Shock Proteins, Calcineurin, Cyclophilin A, Drug Resistance, Fungal, Saccharomyces cerevisiae Proteins, Echinocandins, Lipopeptides, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.